Algert Global’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.9M Sell
765,573
-50,697
-6% -$1.01M 0.18% 159
2026
Q1
$15.7M Sell
816,270
-239,511
-23% -$4.72M 0.24% 107
2025
Q4
$20M Buy
1,055,781
+1,042,551
+7,880% +$19.3M 0.31% 56
2025
Q3
$247K Buy
+13,230
New +$247K ﹤0.01% 1028
2024
Q3
Sell
-23,320
Closed -$359K 1538
2024
Q2
$359K Buy
+23,320
New +$333K 0.01% 1042

Other funds holding SBRA

Algert Global's SBRA Position: Q2 2026 in Review

Algert Global reduced its Sabra Healthcare REIT (SBRA) stake by 6.2% in Q2 2026, selling an estimated $1.01M and leaving 765,573 shares worth $14.9M. The position accounts for 0.18% of the portfolio, ranked #159.

Algert Global first reported a position in SBRA in Q2 2024 and has held it in 5 quarters since. The position peaked at $20M in Q4 2025. 464 funds tracked by Wall St. Rank hold SBRA as of Q2 2026.

  • Algert Global held 765,573 shares of Sabra Healthcare REIT worth $14.9M as of Q2 2026.
  • Algert Global sold 50,697 Sabra Healthcare REIT shares in Q2 2026, an estimated $1.01M.
  • Sabra Healthcare REIT made up 0.18% of Algert Global's portfolio in Q2 2026, its #159 holding.
  • Algert Global first reported a position in Sabra Healthcare REIT in Q2 2024 and has held it in 5 quarters since.
  • Algert Global's Sabra Healthcare REIT position peaked at $20M in Q4 2025.
  • 464 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.